# Glance Fin (NSE: GLANCE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/GLANCE · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹34 Cr, it ranks 3305th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Capital Markets.

Its return on equity was 5.2% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹0 Cr (−63.2% year on year) and net profit −₹4 Cr (−38,500.0%), on a standalone basis. Promoters held 74.34% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹34 Cr |
| ROE | 5.2% (FY25) |
| ROCE | 9.5% (FY25) |
| Debt to equity | 0.08 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹0 Cr | −63.2% | −₹4 Cr | −38,500.0% | −₹17.01 |
| Q3 FY26 | ₹5 Cr | +8.7% | ₹1 Cr | +82.9% | ₹3.33 |
| Q2 FY26 | ₹8 Cr | −26.5% | ₹0 Cr | −92.9% | ₹0.31 |
| Q1 FY26 | ₹1 Cr | +1.3% | ₹0 Cr | −78.0% | ₹0.88 |
| Q4 FY25 | ₹1 Cr | −87.6% | ₹0 Cr | −98.2% | ₹0.06 |
| Q3 FY25 | ₹4 Cr | −11.5% | ₹0 Cr | −6.8% | ₹1.81 |
| Q2 FY25 | ₹11 Cr | +372.9% | ₹1 Cr | +117.8% | ₹4.35 |
| Q1 FY25 | ₹1 Cr | +25.4% | ₹1 Cr | +85.7% | ₹4.05 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹25 Cr | ₹2 Cr |
| FY24 | ₹23 Cr | ₹2 Cr |
| FY23 | ₹8 Cr | −₹0 Cr |
| FY22 | ₹7 Cr | ₹2 Cr |
| FY21 | ₹4 Cr | ₹1 Cr |
| FY20 | ₹5 Cr | ₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 74.34%
- Non-institutions: 25.66%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Lerthai Finance](https://app.pivotnow.in/stock/LERTHAI) | — | ₹35 Cr | — | — |
| [Sylph Ind](https://app.pivotnow.in/stock/SYLPH) | — | ₹35 Cr | — | — |
| [Supra Trends](https://app.pivotnow.in/stock/SUPRATRE) | — | ₹35 Cr | — | — |
| [Sumedha Fiscal](https://app.pivotnow.in/stock/SUMEDHA) | ₹42.65 | ₹34 Cr | 14.1 | — |
| [Swasti Vinayaka](https://app.pivotnow.in/stock/SVARTCORP) | — | ₹34 Cr | — | — |
| [Biogen Pharmach](https://app.pivotnow.in/stock/BIOGEN) | — | ₹34 Cr | — | — |

## Questions and answers

### What is the market cap of Glance Fin?

Glance Fin's market capitalisation is ₹34 Cr (₹34 Cr) at the 19 Oct 2026 close, ranking 3305th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Glance Fin?

Return on equity was 5.2% in FY25 and return on capital employed was 9.5% in FY25 (standalone figures).

### What were Glance Fin's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Glance Fin reported revenue of ₹0 Cr, −63.2% year on year, and net profit of −₹4 Cr, −38,500.0% year on year.

### What is the shareholding pattern of Glance Fin?

As of 30 Jun 2026: promoters 74.34%, non-institutions 25.66%.

### Who are Glance Fin's competitors?

The listed Financials companies closest to Glance Fin by market cap are Lerthai Finance, Sylph Ind, Supra Trends, Sumedha Fiscal, Swasti Vinayaka and Biogen Pharmach.

### Is Glance Fin a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Glance Fin's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on GLANCE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.